← Evidence map

RetractedArticleEBioMedicine2018

The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells.

Jiwei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

39 papers cite it

2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 30146342